ES8202584A1 - Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada. - Google Patents

Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada.

Info

Publication number
ES8202584A1
ES8202584A1 ES496358A ES496358A ES8202584A1 ES 8202584 A1 ES8202584 A1 ES 8202584A1 ES 496358 A ES496358 A ES 496358A ES 496358 A ES496358 A ES 496358A ES 8202584 A1 ES8202584 A1 ES 8202584A1
Authority
ES
Spain
Prior art keywords
stabilizer
liquid
vaccine containing
vaccines
disaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES496358A
Other languages
English (en)
Other versions
ES496358A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8202584A1 publication Critical patent/ES8202584A1/es
Publication of ES496358A0 publication Critical patent/ES496358A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSICION DE UN ESTABILIZANTE PARA VACUNAS VIRALES LIQUIDAS. CONSTA, EN PARTES EN PESO, DE 1,5 A 2,1 PARTES DE GELATINA PARCIALMENTE HIDROLIZADA, DE 7 A 13 PARTES DE UN MONOSACARIDO O DISACARIDO, SACAROSA, LACTOSA O MALTOSA, DE 0,4 A 0,6 PARTES DE UN MEDIO DE CULTIVO DE CEDULAS IN VITRO, DE 0,35 A 0,7 PARTES DE ACIDO L-GLUMATICO, DE 0,75 A 1,3 PARTES DE L-ARGININA Y UNA CANTIDAD DE TAMPON ACIDO, PRINCIPALMENTE TAMPON DE FOSFATO, FISIOLOGICAMENTE ACEPTABLE, ADECUADA PARA MANTENER EL PH ENTRE 6 Y 6,5 APROXIMADAMENTE. ES APLICABLE A VACUNAS VIRALES LIQUIDAS COMO SARAMPION, PAPERAS, RUBEOLA, SINFITIAL RESPIRATORIA Y CITOMEGALOVIRUS.
ES496358A 1979-10-29 1980-10-28 Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada. Granted ES496358A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8906879A 1979-10-29 1979-10-29
US11870380A 1980-02-05 1980-02-05

Publications (2)

Publication Number Publication Date
ES8202584A1 true ES8202584A1 (es) 1982-02-01
ES496358A0 ES496358A0 (es) 1982-02-01

Family

ID=26780218

Family Applications (1)

Application Number Title Priority Date Filing Date
ES496358A Granted ES496358A0 (es) 1979-10-29 1980-10-28 Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada.

Country Status (7)

Country Link
EP (1) EP0028563B1 (es)
DE (1) DE3067376D1 (es)
DK (1) DK159100C (es)
ES (1) ES496358A0 (es)
GR (1) GR70319B (es)
IE (1) IE50276B1 (es)
PT (1) PT71926B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5716823A (en) * 1980-07-03 1982-01-28 Green Cross Corp:The Live mumps vaccine pharmaceutical and stabilizing method
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
MX7528E (es) * 1981-01-09 1989-08-02 New York Blood Center Inc Procedimiento para la preparacion de una vacuna sintetica
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
FR2532548B1 (fr) * 1982-09-03 1985-11-08 Pasteur Institut Nouveau procede de production de vaccins presentant un titre eleve de virus et vaccins tres purifies, a titre eleve de virus, ainsi obtenus
DK331087A (da) * 1986-06-30 1987-12-31 Smith Kline Rit Stabilisator for levende vaccine
JPS63307827A (ja) * 1987-06-08 1988-12-15 Kitasato Inst:The 安定化された生ウイルスワクチンおよびその製造法
AU1633092A (en) * 1991-05-17 1992-11-19 Merck & Co., Inc. Non-stinging vaccine composition
CA2075521C (en) * 1992-05-05 1995-11-28 Kuniaki Koyama Stabilized live vaccine
US6403098B1 (en) * 1996-09-26 2002-06-11 Merck & Co., Inc. Rotavirus vaccine formulations
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
EP0946193A1 (en) * 1996-12-20 1999-10-06 Merck & Co., Inc. Stabilizers for lyophilized vaccines
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
US20040022800A1 (en) * 2000-07-31 2004-02-05 Mark Parrington Respiratory syncytial virus vaccine
WO2006052813A2 (en) 2004-11-05 2006-05-18 Wellstat Biologics Corporation Stable and filterable enveloped virus formulations
US20060141483A1 (en) * 2004-12-23 2006-06-29 Calton Gary J Stabilization of viral compositions
DK1973406T3 (da) 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
JP5285617B2 (ja) 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
RU2567668C2 (ru) 2009-05-26 2015-11-10 Эдванст Бионутришн Корпорейшн Стабильная сухая порошкообразная композиция, содержащая биологически активные микроорганизмы и/или биоактивные материалы, и способ ее изготовления
NZ601017A (en) 2010-01-28 2014-07-25 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
RS57588B1 (sr) 2010-08-13 2018-11-30 Advanced Bionutrition Corp Supstanca za stabilizaciju bioloških materijala za suvo skladištenje
EP3246400B1 (en) 2012-01-09 2019-10-23 Sanofi Pasteur Biologics, LLC Purification of herpes virus
CA2873775C (en) 2012-05-21 2021-04-20 Sanofi Pasteur Limited Herpesvirus compositions and related methods
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
US9480739B2 (en) 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
US9393298B2 (en) 2013-03-15 2016-07-19 Intervet Inc. Liquid stable bovine virus vaccines
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
AR099470A1 (es) * 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
TWI670085B (zh) * 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
WO2017019273A1 (en) 2015-07-29 2017-02-02 Advanced Bionutrition Corporation Stable dry probiotic compositions for special dietary uses
MA56118A (fr) 2019-06-10 2022-04-13 Boehringer Ingelheim Animal Health Usa Inc Vaccin vivant liquide stabilisé

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE641705A (es) * 1963-12-23 1964-06-23
BE665076A (es) * 1963-12-23 1965-12-08
FR2076787A5 (en) * 1970-01-28 1971-10-15 Merieux Inst Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin
NL7115348A (es) * 1970-11-25 1972-05-29
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
IL44143A0 (en) * 1973-02-07 1974-05-16 Wellcome Found Method of inactivating viruses and vaccines prepared thereby
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
DE2816349A1 (de) * 1978-04-14 1979-10-25 Merck & Co Inc Vaccinstabilisator
FR2424031A1 (fr) * 1978-04-24 1979-11-23 Merck & Co Inc Stabilisateur de vaccin
BE866330A (fr) * 1978-04-25 1978-10-25 Merck & Co Inc Procede de fabrication d'un agent de stabilisation de vaccin
LU79529A1 (fr) * 1978-04-26 1978-11-28 Merck & Co Inc Procede de fabrication d'un agent de stabilisation de vaccin

Also Published As

Publication number Publication date
PT71926A (en) 1980-11-01
DE3067376D1 (en) 1984-05-10
DK455880A (da) 1981-04-30
GR70319B (es) 1982-09-10
IE50276B1 (en) 1986-03-19
IE802225L (en) 1981-04-29
DK159100B (da) 1990-09-03
EP0028563A1 (en) 1981-05-13
EP0028563B1 (en) 1984-04-04
ES496358A0 (es) 1982-02-01
DK159100C (da) 1991-02-11
PT71926B (en) 1982-03-31

Similar Documents

Publication Publication Date Title
ES8202584A1 (es) Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada.
DK0500917T3 (da) Vacciner og fremgangsmåder baseret på rekombinante herpes simplex virusser.
ES8705036A1 (es) Procedimiento para preparar una vacuna que comprende un polipeptido fijado a una membrana
ES422961A1 (es) Procedimiento para preparar una suspension de virus.
FI905184A0 (fi) Kimeriska glykoproteiner som innehaoller immunogeniska delar av human parainfluensa-virus typ 3.
ATE79548T1 (de) Herpes simplex virus subunitimpfstoff.
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
GB1430711A (en) Live bovine and method ofvaccination using them
JPS5299289A (en) Preparation of l-arginine by fermentation
CA2116355A1 (en) Infectious bovine rhinotracheitis virus mutants and vaccines
ES432385A1 (es) Un metodo de obtener una cepa de virus de la gripe.
MX9602256A (es) Vacuna contra la enfermedad de marek.
GB1358321A (en) Method od tissue cell culture
GB1243252A (en) Stable poliomyelitis vaccines and process for their manufacture
IL67818A (en) Vaccines comprising ozone inactivated viruses and their production
SU563175A1 (ru) Разбавитель дл сухой вирусвакцины против болезней марека
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
ES468960A1 (es) Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada mejorada
DE3582422D1 (de) Biologische zubereitungen.
FR2290220A2 (fr) Nouveau vaccin antirabique
IE35437L (en) Vaccine from bacteroides nodosus.
GB1512412A (en) Feline viral rhinotracheitis vaccine and method of preparation
Wu Studies on the Cultivation of Human Diploid Cells in Microcarrier Culture.
POWASSAN et al. Moscow MEDITSINSKAYA PARAZITOLOGIYA I PARAZITARNYYE BOLEZNI in Russian Vol 60, No 3, May-Jun 82 (manuscript received 23 Mar 81) pp 13-15 KISLENKO, GS, CHUNIKHIN, SP, RASNITSYN, SP, KURENKOV, VB and IZOTOV, VK, Institute of Poliomyelitis and Viral Encephalitides, USSR Academy of Medical Sciences; Institute of Medical Parasitology and Tropical
Glaner et al. 30-Year record of swine fever vaccine production in Insel Riems.